{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:00Z","timestamp":1792791480802,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005721","name":"Universit\u00e4t Bielefeld","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The decision to maintain or halt antiplatelet medication in septic patients admitted to intensive care units presents a clinical dilemma. This is due to the necessity to balance the benefits of preventing thromboembolic incidents and leveraging anti-inflammatory properties against the increased risk of bleeding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study involves a secondary analysis of data from a prospective cohort study focusing on patients diagnosed with severe sepsis or septic shock. We evaluated the outcomes of 203 patients, examining mortality rates and the requirement for transfusion. The cohort was divided into two groups: those whose antiplatelet therapy was sustained (<jats:italic>n<\/jats:italic>\u2009=\u2009114) and those in whom it was discontinued (<jats:italic>n<\/jats:italic>\u2009=\u200989). To account for potential biases such as indication for antiplatelet therapy, propensity score matching was employed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Therapy continuation did not significantly alter transfusion requirements (discontinued vs. continued in matched samples: red blood cell concentrates 51.7% vs. 68.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.09; platelet concentrates 21.7% vs. 18.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.82; fresh frozen plasma concentrates 38.3% vs. 33.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.7). 90-day survival was higher within the continued group (30.0% vs. 70.0%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and the Log-rank test (7-day survivors; <jats:italic>p<\/jats:italic>\u2009=\u20090.001) as well as Cox regression (both matched samples) suggested an association between continuation of antiplatelet therapy\u2009&lt;\u20097 days and survival (HR: 0.24, 95%-CI 0.10 to 0.63, <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Sepsis severity expressed by the SOFA score did not differ significantly in matched and unmatched patients (both <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings suggest that continuing antiplatelet therapy in septic patients admitted to intensive care units could be associated with a significant survival benefit without substantially increasing the need for transfusion. These results highlight the importance of a nuanced approach to managing antiplatelet medication in the context of severe sepsis and septic shock.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-024-02516-7","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T02:01:43Z","timestamp":1713319303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Continuation of chronic antiplatelet therapy is not associated with increased need for transfusions: a cohort study in critically ill septic patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Christian","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Wauschkuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hahnenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gr\u00fcndling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixten","family":"Selleng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Borgstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Olaf","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Selim","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2516_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"AT Collaboration","year":"2002","unstructured":"Collaboration AT. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71\u201386.","journal-title":"BMJ"},{"key":"2516_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/003335491513000614","volume":"130","author":"Q Gu","year":"2015","unstructured":"Gu Q, Dillon CF, Eberhardt MS, Wright JD, Burt VL. Preventive aspirin and other Antiplatelet Medication Use among U.S. adults aged\u2009\u2265\u200940 years: data from the National Health and Nutrition Examination Survey, 2011\u20132012. Public Health Rep. 2015;130:643\u201354.","journal-title":"Public Health Rep"},{"key":"2516_CR3","first-page":"782573","volume":"2013","author":"JC Valerio-Rojas","year":"2013","unstructured":"Valerio-Rojas JC, Jaffer IJ, Kor DJ, Gajic O, Cartin-Ceba R. Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study. Crit Care Res Pract. 2013;2013:782573.","journal-title":"Crit Care Res Pract"},{"key":"2516_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/CCM.0b013e3181b4275c","volume":"38","author":"J Winning","year":"2010","unstructured":"Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, Losche W. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med. 2010;38:32\u20137.","journal-title":"Crit Care Med"},{"key":"2516_CR5","doi-asserted-by":"crossref","unstructured":"Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in Sepsis. Int J Mol Sci 2017;18.","DOI":"10.3390\/ijms18102200"},{"key":"2516_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.thromres.2010.10.010","volume":"127","author":"Z Li","year":"2011","unstructured":"Li Z, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res. 2011;127:184\u20138.","journal-title":"Thromb Res"},{"key":"2516_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/09537104.2012.724482","volume":"24","author":"GP Otto","year":"2013","unstructured":"Otto GP, Sossdorf M, Boettel J, Kabisch B, Breuel H, Winning J, Losche W. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets. 2013;24:480\u20135.","journal-title":"Platelets"},{"key":"2516_CR8","doi-asserted-by":"crossref","unstructured":"Yuan S, Chen C, Xu F, Han D, Yang R, Zheng S et al. Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease. Int J Clin Pract. 2022; 2022:1\u201368.","DOI":"10.1155\/2022\/1288535"},{"key":"2516_CR9","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/CCM.0b013e318246b9df","volume":"40","author":"DP Eisen","year":"2012","unstructured":"Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med. 2012;40:1761\u20137.","journal-title":"Crit Care Med"},{"key":"2516_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/CCM.0000000000000789","volume":"43","author":"W Chen","year":"2015","unstructured":"Chen W, Janz DR, Bastarache JA, May AK, O\u2019Neal HR, Bernard JR, Ware GR. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med. 2015;43:801\u20137.","journal-title":"Crit Care Med"},{"key":"2516_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11239-017-1525-x","volume":"44","author":"E Gupta","year":"2017","unstructured":"Gupta E, Siddiqi FS, Kunjal R, Faisal M, Al-Saffar F, Bajwa AA, Jones LM, Seeram V, Cury JD, Shujaat A. Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients. J Thromb Thrombolysis. 2017;44:330\u20134.","journal-title":"J Thromb Thrombolysis"},{"key":"2516_CR12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","volume":"370","author":"PJ Devereaux","year":"2014","unstructured":"Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MTV, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494\u2013503.","journal-title":"N Engl J Med"},{"key":"2516_CR13","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1185\/03007990903212682","volume":"25","author":"ND Yeomans","year":"2009","unstructured":"Yeomans ND, Hawkey CJ, Brailsford W, Naesdal J. Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs. Curr Med Res Opin. 2009;25:2785\u201393.","journal-title":"Curr Med Res Opin"},{"key":"2516_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40360-016-0047-z","volume":"17","author":"SA Al Harbi","year":"2016","unstructured":"Al Harbi SA, Tamim HM, Al-Dorzi HM, Sadat M, Arabi YM. Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study. BMC Pharmacol Toxicol. 2016;17:5.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2516_CR15","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1097\/CCM.0000000000002688","volume":"45","author":"C Dupuis","year":"2017","unstructured":"Dupuis C, Garrouste-Orgeas M, Bailly S, Adrie C, Goldgran-Toledano D, Azoulay E, et al. Effect of transfusion on mortality and other adverse events among critically ill septic patients: an observational study using a marginal Structural Cox Model*. Crit Care Med. 2017;45:1972\u201380.","journal-title":"Crit Care Med"},{"key":"2516_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/CCM.0000000000002069","volume":"45","author":"CS Scheer","year":"2017","unstructured":"Scheer CS, Fuchs C, Kuhn S-O, Vollmer M, Rehberg S, Friesecke S, Abel P, Balau V, Bandt C, Meissner K, Hahnenkamp K, Grundling M. Quality Improvement Initiative for severe Sepsis and septic shock reduces 90-Day mortality: a 7.5-Year observational study. Crit Care Med. 2017;45:241\u201352.","journal-title":"Crit Care Med"},{"key":"2516_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17\u201360.","journal-title":"Intensive Care Med"},{"key":"2516_CR18","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00134-013-3044-3","volume":"39","author":"F Lauzier","year":"2013","unstructured":"Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med. 2013;39:2135\u201343.","journal-title":"Intensive Care Med"},{"key":"2516_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1046\/j.1365-2141.1996.5101050.x","volume":"93","author":"R Chakraverty","year":"1996","unstructured":"Chakraverty R, Davidson S, Peggs K, Stross P, Garrard C, Littlewood TJ. The incidence and cause of coagulopathies in an intensive care population. Br J Haematol. 1996;93:460\u20133.","journal-title":"Br J Haematol"},{"key":"2516_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijcard.2017.12.088","volume":"258","author":"G Wolff","year":"2018","unstructured":"Wolff G, Navarese EP, Brockmeyer M, Lin Y, Karathanos A, Ko\u0142odziejczak M, Kubica J, Polzin A, Zeus T, Westenfeld R, Andreotti F, Kelm M, Schulze V. Perioperative aspirin therapy in non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2018;258:59\u201367.","journal-title":"Int J Cardiol"},{"key":"2516_CR21","doi-asserted-by":"publisher","first-page":"g5334","DOI":"10.1136\/bmj.g5334","volume":"349","author":"JD Donze","year":"2014","unstructured":"Donze JD, Ridker PM, Finlayson SRG, Bates DW. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study. BMJ. 2014;349:g5334.","journal-title":"BMJ"},{"key":"2516_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S2213-2600(20)30411-2","volume":"9","author":"DP Eisen","year":"2021","unstructured":"Eisen DP, Leder K, Woods RL, Lockery JE, McGuinness SL, Wolfe R, et al. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. Lancet Respiratory Med. 2021;9:186\u201395.","journal-title":"Lancet Respiratory Med"},{"key":"2516_CR23","doi-asserted-by":"publisher","first-page":"S534","DOI":"10.1097\/CCM.0b013e3181f208ac","volume":"38","author":"J-L Vincent","year":"2010","unstructured":"Vincent J-L. We should abandon randomized controlled trials in the intensive care unit. Crit Care Med. 2010;38:S534\u20138.","journal-title":"Crit Care Med"},{"key":"2516_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1160\/TH14-12-1067","volume":"114","author":"MR Thomas","year":"2015","unstructured":"Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost. 2015;114:449\u201358.","journal-title":"Thromb Haemost"},{"key":"2516_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/CCM.0b013e31819ceb71","volume":"37","author":"M Asaduzzaman","year":"2009","unstructured":"Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, Thorlacius H. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med. 2009;37:1389\u201396.","journal-title":"Crit Care Med"},{"key":"2516_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2362.1995.tb01694.x","volume":"25","author":"M Gawaz","year":"1995","unstructured":"Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest. 1995;25:843\u201351.","journal-title":"Eur J Clin Invest"},{"key":"2516_CR27","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/CCM.0000000000002654","volume":"45","author":"J Trauer","year":"2017","unstructured":"Trauer J, Muhi S, McBryde ES, Al Harbi SA, Arabi YM, Boyle AJ, Cartin-Ceba R, Chen W, Chen Y-T, Falcone M, Gajic O, Godsell J, Gong MN, Kor D, L\u00f6sche W, McAuley DF, O\u2019Neal HR, Osthoff M, Otto GP, Sossdorf M, Tsai M-J, Valerio-Rojas JC, van der Poll T, Violi F, Ware L, Widmer AF, Wiewel MA, Winning J, Eisen DP. Quantifying the effects of prior acetyl-salicylic acid on Sepsis-related deaths: an Individual Patient Data Meta-Analysis using propensity matching. Crit Care Med. 2017;45:1871\u20139.","journal-title":"Crit Care Med"},{"key":"2516_CR28","first-page":"227","volume":"22","author":"L Cioccari","year":"2020","unstructured":"Cioccari L, Luethi N, Duong T, Ryan E, Cutuli SL, Lloyd-Donald P, et al. Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial. Crit Care Resusc. 2020;22:227\u201336.","journal-title":"Crit Care Resusc"},{"key":"2516_CR29","doi-asserted-by":"publisher","first-page":"e001595","DOI":"10.1161\/JAHA.114.001595","volume":"4","author":"M Falcone","year":"2015","unstructured":"Falcone M, Russo A, Cangemi R, Farcomeni A, Calvieri C, Barill\u00e0 F, Scarpellini MG, Bertazzoni G, Palange P, Taliani G, Venditti M, Violi F. Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. J Am Heart Assoc. 2015;4:e001595.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2516_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00134-022-06634-z","volume":"48","author":"F Angriman","year":"2022","unstructured":"Angriman F, Rosella LC, Lawler PR, Ko DT, Wunsch H, Scales DC. Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study. Intensive Care Med. 2022;48(4):448\u201357.","journal-title":"Intensive Care Med"},{"key":"2516_CR31","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","volume":"35","author":"MR Thomas","year":"2015","unstructured":"Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, Dockrell DH, Sabroe I, Storey RF. Platelet P2Y12 inhibitors reduce systemic inflammation and its Prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol. 2015;35:2562\u201370.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2516_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/archinternmed.2009.42","volume":"169","author":"E Blasco-Colmenares","year":"2009","unstructured":"Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med. 2009;169:788\u201396.","journal-title":"Arch Intern Med"},{"key":"2516_CR33","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.jvs.2013.05.092","volume":"58","author":"C Saadeh","year":"2013","unstructured":"Saadeh C, Sfeir J. Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery. J Vasc Surg. 2013;58:1586\u201392.","journal-title":"J Vasc Surg"},{"key":"2516_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1055\/s-0035-1556730","volume":"41","author":"N Semeraro","year":"2015","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M. Coagulopathy of Acute Sepsis. Semin Thromb Hemost. 2015;41:650\u20138.","journal-title":"Semin Thromb Hemost"},{"key":"2516_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00134-015-4171-9","volume":"42","author":"MA Wiewel","year":"2016","unstructured":"Wiewel MA, de Stoppelaar SF, van Vught LA, Frencken JF, Hoogendijk AJ, Klein Klouwenberg PMC, Horn J, Bonten MJ, Zwinderman AH, Cremer OL, Schultz MJ, van der Poll T. Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis. Intensive Care Med. 2016;42:352\u201360.","journal-title":"Intensive Care Med"},{"key":"2516_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1164\/rccm.201209-1718OC","volume":"187","author":"P Kruger","year":"2013","unstructured":"Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, et al. A Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care patients with severe Sepsis. Am J Respir Crit Care Med. 2013;187:743\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"2516_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.amjmed.2014.10.057","volume":"128","author":"A Deshpande","year":"2015","unstructured":"Deshpande A, Pasupuleti V, Rothberg MB. Statin therapy and mortality from Sepsis: a Meta-analysis of Randomized trials. Am J Med. 2015;128:410\u2013e4171.","journal-title":"Am J Med"},{"key":"2516_CR38","first-page":"31","volume":"97","author":"M Chen","year":"2018","unstructured":"Chen M, Ji M, Si X. The effects of Statin Therapy on Mortality in patients with Sepsis: a Meta-analysis of Randomized trials. Medicine. 2018;97:31.","journal-title":"Medicine"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02516-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T02:01:51Z","timestamp":1713319311000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02516-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"25 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present single centre study was conducted as a secondary analysis of a prospective observational trial that was performed to evaluate the long-term effects of a local continuous sepsis training program []. The study was performed according to the German data protection rules. The local ethics committee (Ethikkomission an der Universit\u00e4tsmedizin Greifswald) approved the study and granted a waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.G.: The author declares that he received honoraria for lectures and research grants from bioM\u00e9rieux Deutschland, Becton Dickinson GmbH, Accelerate Diagnostics, Curetis GmbH, and MSD Sharp & Dohme GmbH, outside the submitted work.T.T.: The author reports personal fees from Bristol Myers Squibb and personal fees from Bayer, Daichii Sankyo, Pfizer, Novo Nordisk and Novartis, outside the submitted work.S.R.: The author is a medical advisor for Fresenius Kabi Germany and received honoraria and travel expenses from Amomed Pharma and CSL Behring, outside the submitted work.S.S.S.: The author declares that he received honoraria for lectures from Pfizer, outside the submitted work.C.F., C.S., S.W., M.V., K.M., K.H., S.S., R.B. and S.-O.K. declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}